The DSS and OS of patients with stage II disease also showed a trend towards improvement, but the differences versus Group S did not reach statistical significance.
← all excerpts
Oxaliplatin-based adjuvant chemotherapy without radiotherapy can improve the survival of locally-advanced rectal cancer.
1
—
—